MEPs accuse the European Commission of caving in to US pharmaceutical interests after a trade deal with Trump.
Emese Grancsa
International
Credit: Jacquelyn Martin / AP / Profimedia
Always see our news on Google
Ursula von der Leyen has been criticized by cross-party MEPs over the trade deal with Donald Trump, which excludes pharmaceuticals from tariffs but allows a 15% cap. Many voices in the European People's Party (EPP) and other political groups believe the deal favors the US and weakens the European Union's position. Additional critics are calling for transparency and publication of the details of the deal, pointing out that while economically it is an improvement, it is a political defeat for the EU.
Sources
Eurodeputaţii o acuză pe Ursula von der Leyen că și-a depășit mandatul și a cedat în faţa intereselor americane
Eurodeputații critică acordul negociat de către Ursula von der Leyen cu Donald Trump: „Ambele părţi trebuie să câştige ceva”
'O zi sumbră pentru Europa'. Franța critică acordul comercial dintre UE și SUA
UE: „Nu am luat încă nicio decizie cu privire la web tax”
Latest News
14:32
Russia, first reaction after Aleksandar Vučić’s defeat in the elections in Serbia
14:28
SANITAS threatens protests and a general strike if the new Government does not address healthcare demands
14:18
The European Union introduces a two-euro handling fee for parcels from outside the bloc, including orders from Temu and AliExpress
14:15
EEA: approximately 60,000 schools and 15,000 medical facilities in Europe are located in areas with transport noise of at least 55 dB
14:04
A man was arrested after entering the Alba Iulia Police Department with an airsoft gun and a training grenade and asking to be shot
See more news
NEWS ON THE SAME TOPICS
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
